STOCK TITAN

Veralto SVP Trivedi exercises options and sells shares

The option records listed expiration dates of February 24, 2029, for 9,907 options and November 15, 2029, for 26,520 options.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Surekha Trivedi, Veralto Corp’s SVP, Strategy & Sustainability, exercised fully vested options on October 30, 2026, for 9,907 shares at $37.92 and 26,520 shares at $47.78. She acquired the corresponding common shares and sold 9,907 and 26,520 shares at $108.89 per share. The common-stock acquisitions and sales were effected pursuant to a previously disclosed Rule 10b5-1 trading plan.

Insider Trivedi Surekha
Role SVP, Strategy & Sustainability
Sold 36,427 shs ($3.97M)
Approx. gross sale proceeds $3.97M
Approx. exercise cost $1.64M
Approx. pre-tax spread $2.32M
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) F2 9,907 $37.92 $376K
Exercise Employee Stock Option (Right to Buy) F2 26,520 $47.78 $1.27M
Exercise Common Stock F1 9,907 $37.92 $376K
Sale Common Stock F1 9,907 $108.89 $1.08M
Exercise Common Stock F1 26,520 $47.78 $1.27M
Sale Common Stock F1 26,520 $108.89 $2.89M
Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 8,565 shares (Direct)
Footnotes (2)
  1. F1. The reported transaction was effected pursuant to a previously disclosed Rule 10b5-1 trading plan by the reporting person on May 18, 2026.
  2. F2. Represents stock options that are fully vested.
Options exercised 9,907 shares October 30, 2026
Option exercise price $37.92 per share 9,907 options exercised on October 30, 2026
Options exercised 26,520 shares October 30, 2026
Option exercise price $47.78 per share 26,520 options exercised on October 30, 2026
Common shares sold 9,907 shares at $108.89 per share October 30, 2026
Common shares sold 26,520 shares at $108.89 per share October 30, 2026
Rule 10b5-1 trading plan financial
"effected pursuant to a previously disclosed Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Employee Stock Option (Right to Buy) financial
"Employee Stock Option (Right to Buy)"
fully vested financial
"stock options that are fully vested"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VLTO shares did Surekha Trivedi sell, and at what price?

Surekha Trivedi sold 9,907 common shares and 26,520 common shares on October 30, 2026, each at $108.89 per share. The sales were effected pursuant to a previously disclosed Rule 10b5-1 trading plan.

What VLTO options did Surekha Trivedi exercise?

On October 30, 2026, Surekha Trivedi exercised fully vested options covering 9,907 shares at an exercise price of $37.92 and 26,520 shares at $47.78. She acquired the corresponding common shares, which were reported as sold that day.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Trivedi Surekha

(Last)(First)(Middle)
C/O VERALTO CORPORATION
225 WYMAN STREET, SUITE 250

(Street)
WALTHAM MASSACHUSETTS 02451

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Veralto Corp [ VLTO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Strategy & Sustainability
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/30/2026M9,907A(1)$37.9218,472D
Common Stock10/30/2026S9,907D(1)$108.898,565D
Common Stock10/30/2026M26,520A(1)$47.7835,085D
Common Stock10/30/2026S26,520D(1)$108.898,565D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$37.9210/30/2026M9,907 (2)02/24/2029Common Stock9,907$37.920D
Employee Stock Option (Right to Buy)$47.7810/30/2026M26,520 (2)11/15/2029Common Stock26,520$47.780D
Explanation of Responses:
1. The reported transaction was effected pursuant to a previously disclosed Rule 10b5-1 trading plan by the reporting person on May 18, 2026.
2. Represents stock options that are fully vested.
Remarks:
/s/ James Tanaka, as attorney-in-fact11/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading